Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00864682 · ClinicalTrials.gov registry record · Phase 4
Preventing Propofol-associated Injection Pain
A Phase 4 study of Pain, sponsored by Benaroya Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT00864682: Completed Phase 4 study of Pain, sponsored by Benaroya Research Institute.
NCT00864682 is a Phase 4 study of Pain that has completed, run by Benaroya Research Institute. The registered enrollment target is 156 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00864682, a Phase 4 study of Pain, has completed, sponsored by Benaroya Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with propofol will be superior to lidocaine administered directly into the vein, under tourniquet control, prior to injection of propofol. Both groups are expected to be superior to placebo.
Primary Outcome
11 point verbal pain score (VPS) 0=no pain; 10=worst imaginable pain
Conditions Studied
Interventions
- DRUG Saline
- DRUG Lidocaine / propofol admixture
- DRUG lidocaine pretreatment
Study Locations (1)
Washington
- Benaroya Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-04 |
| Phase | Phase 4 |
What the finished NCT00864682 record still lists
NCT00864682 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.
NCT00864682 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00864682 about?
NCT00864682 is a clinical study titled "Preventing Propofol-associated Injection Pain". Injection of propofol is associated with discomfort in subsets of patients. Local anesthetics have been shown to attenuate this response in some patients. This randomized, double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with propofol will be superior to lidocaine adm...
What is the current status of trial NCT00864682?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2008-01. Estimated completion is 2009-04.
What conditions does trial NCT00864682 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00864682?
The interventions under investigation include: Saline (DRUG), Lidocaine / propofol admixture (DRUG), lidocaine pretreatment (DRUG).
Who is sponsoring clinical trial NCT00864682?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00864682 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00864682's enrollment target sits among peer trials
156 112th of 374 higher than 263 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia